NCT04485546 Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis Status COMPLETED Phase PHASE4
NCT04276558 REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients Status COMPLETED Phase PHASE2
NCT02707120 Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis Status WITHDRAWN Phase PHASE4
NCT02227147 Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK Status COMPLETED Phase PHASE2
NCT01756456 Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. Status COMPLETED Phase PHASE1/PHASE2